Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery

被引：0
作者：
Erickson, Nicholas J. [1 ]
Stavarache, Mihaela [2 ]
Tekedereli, Ibrahim [1 ]
Kaplitt, Michael G. [2 ]
Markert, James M. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA
[2] Weill Cornell Med, Dept Neurol Surg, Lab Mol Neurosurg, New York, NY USA
来源：
WORLD NEUROSURGERY | 2025年 / 194卷
关键词：
Magnetic resonance-guided focused ultrasound; Magnetic Malignant glioma; Oncolytic viral therapy; INTENSITY FOCUSED ULTRASOUND; BRAIN-BARRIER DISRUPTION; LIPOSOMAL DOXORUBICIN; RIBONUCLEOTIDE REDUCTASE; GLIOBLASTOMA-MULTIFORME; ENHANCED DELIVERY; TUMOR BARRIER; VIRUS; REPLICATION; VIROTHERAPY;
D O I：
10.1016/j.wneu.2024.123595
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors present a comprehensive review on the history and development of oncolytic herpes simplex viral therapies for malignant glioma with a focus on mechanisms of delivery in prior and ongoing clinical trials. This review highlights the advancements made with regard to delivering these therapies to a highly complex immunologic environment in the setting of the blood-brain and blood-tumor barrier in a safe and effective manner.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses
    Cozzi, PJ
    Burke, PB
    Bhargav, A
    Heston, WDW
    Huryk, B
    Scardino, PT
    Fong, Y
    PROSTATE, 2002, 53 (02) : 95 - 100
  • [32] The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy
    Miao, L.
    Fraefel, C.
    Sia, K. C.
    Newman, J. P.
    Mohamed-Bashir, S. A.
    Ng, W. H.
    Lam, P. Y. P.
    BRITISH JOURNAL OF CANCER, 2014, 110 (01) : 94 - 106
  • [33] Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
    Gillory, Lauren A.
    Megison, Michael L.
    Stewart, Jerry E.
    Mroczek-Musulman, Elizabeth
    Nabers, Hugh C.
    Waters, Alicia M.
    Kelly, Virginia
    Coleman, Jennifer M.
    Markert, James M.
    Gillespie, G. Yancey
    Friedman, Gregory K.
    Beierle, Elizabeth A.
    PLOS ONE, 2013, 8 (10):
  • [34] Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
    Ning, Jianfang
    Wakimoto, Hiroaki
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [35] Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers
    Wong, Jennifer
    Lee, Cleo
    Zhang, Kevin
    Rennie, Paul S.
    Jia, William
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (09) : 1786 - 1794
  • [36] Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer
    Kimata, Hideto
    Imai, Tsuneo
    Kikumori, Toyone
    Teshigahara, Osamu
    Nagasaka, Tetsuro
    Goshima, Fumi
    Nishlyama, Yukihiro
    Nakao, Akimasa
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (08) : 1078 - 1084
  • [37] Pilot Study of Oncolytic Viral Therapy Using Mutant Herpes Simplex Virus (HF10) Against Recurrent Metastatic Breast Cancer
    Hideto Kimata
    Tsuneo Imai
    Toyone Kikumori
    Osamu Teshigahara
    Tetsuro Nagasaka
    Fumi Goshima
    Yukihiro Nishiyama
    Akimasa Nakao
    Annals of Surgical Oncology, 2006, 13 : 1078 - 1084
  • [38] Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery
    Gaston, David C.
    Whitley, Richard J.
    Parker, Jacqueline N.
    FUTURE VIROLOGY, 2011, 6 (03) : 321 - 340
  • [39] Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
    Duebgen, Matthias
    Martinez-Quintanilla, Jordi
    Tamura, Kaoru
    Hingtgen, Shawn
    Redjal, Navid
    Wakimoto, Hiroaki
    Shah, Khalid
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06):
  • [40] Hypoxia Moderates γ134.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures
    Friedman, Gregory K.
    Haas, Marilyn C.
    Kelly, Virginia M.
    Markert, James M.
    Gillespie, George Yancey
    Cassady, Kevin A.
    TRANSLATIONAL ONCOLOGY, 2012, 5 (03): : 200 - 207
12345